Franklin US Mega Cap 100 UCITS ETF

PhysicalIndex replication
AccumulatingDistribution policy
0.09 %TER
£77.88M Fund size
101Number of positions
— TD
50.38 %Top 10 share
USDCurrency
4SRI

Current price

£25.15
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

Objectives and Investment Policy Franklin US Mega Cap 100 UCITS ETF (the “Fund”) aims to provide exposure to large capitalisation stocks in the United States. The Fund seeks to track the performance of the Solactive US Mega Cap 100 Select Index -NR (the “Index”) as closely as possible, regardless of whether the Index level rises or falls, while seeking to minimise as far as possible the tracking error between the Fund's performance and that of the Index. The Index is a broad free float market-capitalisation weighted index which captures the largest 100 companies listed on the US stock market. The Index is derived from the Solactive Global Benchmark Series which includes approximately 1,500 companies on the US stock market. Index constituents are selected and weighted by free-float market capitalisation. The Index is rebalanced quarterly in February, May, August and November. The securities in which the Fund invests will be primarily listed or traded on recognised markets in the United States in accordance with the limits set out in the UCITS Regulations. The Fund may use derivatives for efficient portfolio management purposes only. The investment manager will aim to replicate the Index by holding all of the Index securities in a similar proportion to their weighting in the Index. However, in certain circumstances where full replication of the Index is not reasonably practical or possible, the Fund may hold only those of the Index securities which are available or may invest in instruments that are not included in the Index but which the investment manager believes will help the Fund replicate the Index, e.g. securities which provide similar price and yield performance and risk profiles to constituents of the Index. . Although the Index is generally well diversified, because of the market it reflects it contains constituents issued by the same body that may represent more than 10% of the Index. Accordingly, the Fund is permitted to hold positions in individual constituents of the Index issued by the same body of up to 20% of the Fund’s Net Asset Value. The Fund's shares are listed and traded on one or more stock exchanges. In normal circumstances, only authorised participants (e.g. select financial institutions) may deal in shares directly with the Fund. Other investors can deal in shares daily through a broker on stock exchange(s) on which the shares are traded. Terms to Understand Large-capitalisation stock: stock of companies with large market capitalisation generally accounting accumulatively for the top 70% of the capitalisation of a domestic stock market. Derivatives: Financial instruments whose characteristics and value depend on the performance of one or more underlying assets, typically securities, indexes, currencies or interest rates. Large-capitalisation stock: stock of companies with large market capitalisation generally accounting accumulatively for the top 70% of the capitalisation of a domestic stock market. Free float: only shares available to international investors rather than all of a company's issued shares are used in calculating the Underlying Index. Free float market capitalisation: the share price of a company multiplied by the number of shares available to international investors. Treatment of Income: For accumulation shares, income from investments is reinvested in the Fund and reflected in the price of shares. The Fund may appeal to investors looking to track the performance of large capitalisation stocks in the United States, and who are willing to hold their investment over the medium to long term, for a minimum period of 3 to 5 years. The Fund may be suitable for investors who do not have specific knowledge and/or experience of financial markets and who understand that they may not get back the full amount invested in the Fund.

Return

Here you can see the performance (incl. distributions) of the Franklin US Mega Cap 100 UCITS ETF.

Period Perfor­mance
1 Week-4.95 %
1 Month-6.85 %
3 Months-3.82 %
6 Months-1.61 %
1 Year+6.70 %
3 Years—
5 Years—
10 Years—
Since inception +34.71 %(21.41 % p.a.)
Year Perfor­mance
YTD+6.40 %
2025+16.24 %
2024—
2023—
2022—
2021—
As of: 19 Nov 2026. Performance displayed in GBP

Master data

Key master data for the Franklin US Mega Cap 100 UCITS ETF

Total expense ratio (TER) 0.09 %
Index replication Physical
Replication method Full
Distribution policy Accumulating
Fund size £77.88M
Fund launch 7 May 2025
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
4 · medium risk class

Risk metrics

Key risk and analysis metrics for the Franklin US Mega Cap 100 UCITS ETF

Volatility
13.44 % 1 Year
— 3 Years
— 5 Years
max. Drawdown
-7.18 % 1 Year
— 3 Years
— 5 Years
Sharpe Ratio
0.43 1 Year
— 3 Years
— 5 Years
XLM
25.31

Information about the Solactive US Mega Cap 100 Select NR USD Index

Index name Solactive US Mega Cap 100 Select NR USD (1)
Included securities 107
Stock positions 101
Bond positions 0
Cash and other positions 6

More ETFs tracking the Solactive US Mega Cap 100 Select NR USD Index

Here you can find alternative index funds for the Solactive US Mega Cap 100 Select NR USD.

Fund nameWKNTER
No results

Frequently asked questions

Here you will find all answers to your questions about the Franklin US Mega Cap 100 UCITS ETF

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.